The swift, unambiguous identification of disease markers in low concentrations is fundamental to early detection and good prognosis. Immunoassays, which are analytical disease diagnostic tests, provide quantitative recognition based on antibody-antigen specificity. The cornucopia of available antibodies has led to the development of assays for almost any perceivable antigen, making them a pillar of modern diagnostics. The existence of two antibodies to one antigen allows the immobilisation of capture antibodies, which bind an antigen, onto which a detection antibody can be bound forming a sandwich structure. These assays rely on radio, fluorescent or enzymatic labelled detection antibody for readout. These suffer from several limitations, s...